Skip to content

Clinical trials

Completed Pathologic Processes trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Status: Completed Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20094
20111
20141
20151
20172
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated2
Aeris Therapeutics1
AstraZeneca1
BBB-Therapeutics B.V.1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Fondation Ophtalmologique Adolphe de Rothschild1
GlaxoSmithKline1
Mundipharma Research Limited1
Pfizer1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes12
Lung Diseases5
Respiratory Tract Diseases5
Cystic Fibrosis3
Genetic Diseases, Inborn3
Pancreatic Diseases3
Candidemia2
Candidiasis2
Candidiasis, Invasive2
Digestive System Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.